Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast
Authors:
- Per Seest JørgensenPJPer Seest Jørgensen
- Torsten WarmingTWTorsten Warming
- Kim HansenKHKim Hansen
- Charlotte PaltvedCPCharlotte Paltved
- Helle Vibeke BergHBHelle Vibeke Berg
- René JensenRJRené Jensen
- René Kirchhoff-JensenRKRené Kirchhoff-Jensen
- Lasse KjærLKLasse Kjær
- Nina KerboucheNKNina Kerbouche
- Per Leth-EspensenPLPer Leth-Espensen
- Eva NarvestadENEva Narvestad
- Søren Wistisen RasmussenSRSøren Wistisen Rasmussen
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 105 (6) , 477-480
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgeryBritish Journal of Haematology, 1999
- A comparison of acetylsalicylic acid with low-molecular-weight heparin for prophylaxis of deep-vein thrombosis in outpatients with injuries and immobilizing bandages of the lower limbDer Unfallchirurg, 1998
- Triplex us in the diagnosis of asymptomatic deep venous thrombosisActa Radiologica, 1997
- Deep venous thrombosis and pulmonary embolism following cast immobilization of the lower extremityThe Journal of Foot and Ankle Surgery, 1996
- Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the legThe Lancet, 1995